Skip to main content
. 2023 Jan 31;15(3):882. doi: 10.3390/cancers15030882
BMs brain metastases
EOR extent of resection
SF sodium fluorescein
KPS Karnofsky Performance Status
NSCLC non-small cell lung cancer
SCLC small cell lung cancer
BBB blood-brain barrier
OS overall survival
QoL quality of life
FGS fluorescence-guided surgery
HGGs high-grade gliomas
5-ALA 5-aminolevulinic acid
FDA Food and Drug Administration
CUCH Chongqing University Cancer Hospital
MRI magnetic resonance imaging
GTR gross total resection
RANO-BM Response Assessment in Neuro-Oncology Brain Metastases
N no residual
U unmeasurable residual
M measurable residual
HR hazard ratios
ICG indocyanine green